BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16650916)

  • 1. Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus.
    Hamilton-West K
    Vaccine; 2006 Jun; 24(24):5183-91. PubMed ID: 16650916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mumps vaccine performance among university students during a mumps outbreak.
    Cortese MM; Jordan HT; Curns AT; Quinlan PA; Ens KA; Denning PM; Dayan GH
    Clin Infect Dis; 2008 Apr; 46(8):1172-80. PubMed ID: 18444852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of mumps and MMR vaccination among university students in England: an online survey.
    Bolton-Maggs D; Conrad D; Keenan A; Lamden K; Ghebrehewet S; Vivancos R
    Vaccine; 2012 Jul; 30(34):5081-5. PubMed ID: 22705081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of students' willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study.
    Donkers HW; Hautvast JL; Akkermans RP; Swaan CM; Ruijs WL; Hulscher ME
    BMC Public Health; 2015 Jun; 15():575. PubMed ID: 26092263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.
    Rota JS; Turner JC; Yost-Daljev MK; Freeman M; Toney DM; Meisel E; Williams N; Sowers SB; Lowe L; Rota PA; Nicolai LA; Peake L; Bellini WJ
    J Med Virol; 2009 Oct; 81(10):1819-25. PubMed ID: 19697404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing incidence of mumps in Scotland: options for reducing transmission.
    Donaghy M; Cameron JC; Friederichs V
    J Clin Virol; 2006 Feb; 35(2):121-9. PubMed ID: 16289903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mumps in a boarding school: description of an outbreak and control measures.
    Mackenzie DG; Craig G; Hallam NF; Moore J; Stevenson J
    Br J Gen Pract; 2006 Jul; 56(528):526-9. PubMed ID: 16834879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.
    Cardemil CV; Dahl RM; James L; Wannemuehler K; Gary HE; Shah M; Marin M; Riley J; Feikin DR; Patel M; Quinlisk P
    N Engl J Med; 2017 Sep; 377(10):947-956. PubMed ID: 28877026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of mumps in a vaccinated child population: a question of vaccine failure?
    Vandermeulen C; Roelants M; Vermoere M; Roseeuw K; Goubau P; Hoppenbrouwers K
    Vaccine; 2004 Jul; 22(21-22):2713-6. PubMed ID: 15246601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mumps outbreak on a university campus--California, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(48):986-9. PubMed ID: 23222373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.
    Shah M; Quinlisk P; Weigel A; Riley J; James L; Patterson J; Hickman C; Rota PA; Stewart R; Clemmons N; Kalas N; Cardemil C;
    Clin Infect Dis; 2018 Jan; 66(1):81-88. PubMed ID: 29020324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak.
    Abedi GR; Mutuc JD; Lawler J; Leroy ZC; Hudson JM; Blog DS; Schulte CR; Rausch-Phung E; Ogbuanu IU; Gallagher K; Kutty PK
    Vaccine; 2012 Nov; 30(49):7052-8. PubMed ID: 23041123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting parents' decisions on MMR immunisation: a mixed method investigation.
    Gellatly J; McVittie C; Tiliopoulos N
    Fam Pract; 2005 Dec; 22(6):658-62. PubMed ID: 16024553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006.
    Marin M; Quinlisk P; Shimabukuro T; Sawhney C; Brown C; Lebaron CW
    Vaccine; 2008 Jul; 26(29-30):3601-7. PubMed ID: 18539365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of the mumps component of the MMR vaccine: a case control study.
    Harling R; White JM; Ramsay ME; Macsween KF; van den Bosch C
    Vaccine; 2005 Jul; 23(31):4070-4. PubMed ID: 15950329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.
    Livingston KA; Rosen JB; Zucker JR; Zimmerman CM
    Vaccine; 2014 Jan; 32(3):369-74. PubMed ID: 24252695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.